Printer Friendly

MannKind, One Drop sign collaboration agreement for BluHale integration.

MannKind Corporation announced that they have signed a collaborative agreement that is intended to integrate MannKind's BluHale accessory device into the One Drop platform. BluHale is a Bluetooth-connected accessory that attaches to the Afrezza inhaler and is designed to convey real-time information about inhalation effort and insulin dose. The goal of this collaboration is to provide a seamless experience for Afrezza patients, including automatic tracking of their insulin doses as well as other important health information on the One Drop platform. The agreement is expected to bring One Drop's award winning user experience to Afrezza users, empowering them with AI-enabled glucose forecasts, predictive insights, and the opportunity to connect one-on-one with One Drop's certified diabetes educators, an educational service that has been recognized by the American Diabetes Association.

COPYRIGHT 2019 The Fly
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2019 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:The Fly
Date:Aug 5, 2019
Words:128
Previous Article:Universal Logistics commences 'Dutch auction' to purchase up to 300,000 shares.
Next Article:U.S. equities have plunged.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters